COVID-19: SARS-CoV-2 Transmission Probable Through Fecal Aerosols
A case of COVID-19 transmission in a high-rise apartment complex in China demonstrates the probable transmission of SARS-CoV-2 through fecal aerosols.
COVID19
Reducing COVID-19 Spread: Quarantine vs Active Monitoring of Contacts
Considering the impact quarantine has on resources and individual liberty, it is important to evaluate under what conditions individual quarantine can more effectively control COVID-19 than active monitoring.
Pneumothorax Reported as Complication of COVID-19
Pneumothorax is being reported as a complication of COVID-19, and has higher incidence among men and lower survival among older patients.
Dexamethasone May Improve Clinical Outcomes in COVID-19
Patients hospitalized with COVID-19 and moderate to severe ARDS who were treated with dexamethasone experienced more ventilator-free days compared to standard care.
Antibody Therapy May Reduce COVID-19 Hospitalizations
The ongoing randomized, double-blind, placebo-controlled BLAZE-1 trial is investigating the treatment in adult patients with mild to moderate COVID-19 symptoms who are not currently hospitalized.
COVID-19-Associated Hyperinflammation Linked to Escalation of Respiratory Support, Survival
Researchers evaluated a specific phenotype of COVID-19-associated hyperinflammation and its association with escalation of patient care.
Effectiveness of Inhaled COVID-19 Vaccines to Be Studied
Researchers have announced plans for a study to assess the effectiveness of 2 experimental COVID-19 vaccines when they are inhaled, rather than injected.
COVID-19 May Not Be Characterized by Cytokine Storm
The findings of a preliminary analysis suggest that COVID-19 may not be characterized by cytokine storm and therefore the benefit of anticytokine therapies remains to be determined.
Study to Examine Efficacy of Canakinumab in COVID-19 With Acute Myocardial Injury
Recruitment has begun for study examining the efficacy of canakinumab for the treatment of patients with COVID-19 and acute myocardial injury.
Icatibant Treatment Improves Oxygenation in COVID-19 Patients
Icatibant, a bradykinin 2 receptor antagonist, may improve oxygenation in patients with coronavirus disease 2019 (COVID-19).
-
Loading...
-
Loading...
Next post in Lung Infection
